LIVE
A cyclic 7-amino-acid synthetic peptide (bremelanotide, CAS 189691-06-3) derived from the alpha-MSH scaffold of Melanotan II. Non-selective agonist of the MC1/MC3/MC4/MC5 melanocortin receptors, with the hypothalamic MC4R activity driving increased sexual desire and arousal. FDA-approved by Palatin Technologies as Vyleesi (June 2019) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) — one of only two FDA-approved drugs for female sexual dysfunction.
For research purposes only. Not medical advice.
Puratek Peptides currently lists PT-141 at $3.15/mg, the lowest indexed price across 19 tracked research peptide vendors.
PT-141 ranges from $2.06/mg to $4.90/mg across 24 listings from 19 research peptide vendors, normalized to USD per milligram and refreshed daily.
19 research peptide vendors currently list PT-141 on PeptideScouter, with 15 in stock right now. We track 24 active listings across size and kit variants.
PT-141's CAS Registry Number is 189691-06-3. It is also sold as Bremelanotide.
